C141H152F15N19O18 — CID 159702516
N-[3-[2-[bis(2-hydroxyethyl)amino]-6-(oxan-4-yl)-4-pyridinyl]-4-methylphenyl]-2-(1,1-difluoroethyl)pyridine-4-carboxamide;N-[3-[2-[bis(2-hydroxyethyl)amino]-6-(oxan-4-yl)-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[3-[2-(4-fluorooxan-4-yl)-6-(2-hydroxyethoxy)-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[5-[2-(4-hydroxypiperidin-1-yl)-6-(oxan-4-yl)-4-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[5-[2-(4-hydroxypiperidin-1-yl)-6-(oxan-4-yl)-4-pyridinyl]-6-methyl-3-pyridinyl]-2-(trifluoromethyl)pyridine-4-carboxamide (PubChem CID 159702516) has the molecular formula C141H152F15N19O18 and a molecular weight of 2685.85 g/mol. Its IUPAC name is N-[3-[2-[bis(2-hydroxyethyl)amino]-6-(oxan-4-yl)-4-pyridinyl]-4-methylphenyl]-2-(1,1-difluoroethyl)pyridine-4-carboxamide;N-[3-[2-[bis(2-hydroxyethyl)amino]-6-(oxan-4-yl)-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[3-[2-(4-fluorooxan-4-yl)-6-(2-hydroxyethoxy)-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[5-[2-(4-hydroxypiperidin-1-yl)-6-(oxan-4-yl)-4-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[5-[2-(4-hydroxypiperidin-1-yl)-6-(oxan-4-yl)-4-pyridinyl]-6-methyl-3-pyridinyl]-2-(trifluoromethyl)pyridine-4-carboxamide.
| Compound Name | N-[3-[2-[bis(2-hydroxyethyl)amino]-6-(oxan-4-yl)-4-pyridinyl]-4-methylphenyl]-2-(1,1-difluoroethyl)pyridine-4-carboxamide;N-[3-[2-[bis(2-hydroxyethyl)amino]-6-(oxan-4-yl)-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[3-[2-(4-fluorooxan-4-yl)-6-(2-hydroxyethoxy)-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[5-[2-(4-hydroxypiperidin-1-yl)-6-(oxan-4-yl)-4-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[5-[2-(4-hydroxypiperidin-1-yl)-6-(oxan-4-yl)-4-pyridinyl]-6-methyl-3-pyridinyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
|---|---|
| PubChem CID | 159702516 |
| Molecular Formula | C141H152F15N19O18 |
| Molecular Weight | 2685.85 g/mol |
| Exact Mass | 2684.13 |
| IUPAC Name | N-[3-[2-[bis(2-hydroxyethyl)amino]-6-(oxan-4-yl)-4-pyridinyl]-4-methylphenyl]-2-(1,1-difluoroethyl)pyridine-4-carboxamide;N-[3-[2-[bis(2-hydroxyethyl)amino]-6-(oxan-4-yl)-4-pyridinyl]-4-methylphenyl]-3-(trifluoromethyl)benzamide;N-[3-[2-(4-fluorooxan-4-yl)-6-(2-hydroxyethoxy)-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide;N-[5-[2-(4-hydroxypiperidin-1-yl)-6-(oxan-4-yl)-4-pyridinyl]-6-methyl-3-pyridinyl]-3-(trifluoromethyl)benzamide;N-[5-[2-(4-hydroxypiperidin-1-yl)-6-(oxan-4-yl)-4-pyridinyl]-6-methyl-3-pyridinyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
| SMILES | Cc1ccc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(C2CCOCC2)nc(N(CCO)CCO)c1.Cc1ccc(NC(=O)c2ccnc(C(C)(F)F)c2)cc1-c1cc(C2CCOCC2)nc(N(CCO)CCO)c1.Cc1ccc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(OCCO)nc(C2(F)CCOCC2)c1.Cc1ncc(NC(=O)c2cccc(C(F)(F)F)c2)cc1-c1cc(C2CCOCC2)nc(N2CCC(O)CC2)c1.Cc1ncc(NC(=O)c2ccnc(C(F)(F)F)c2)cc1-c1cc(C2CCOCC2)nc(N2CCC(O)CC2)c1 |
| InChI | InChI=1S/C29H31F3N4O3.C29H32F3N3O4.C29H34F2N4O4.C28H30F3N5O3.C26H25F4N3O4/c1-18-25(16-23(17-33-18)34-28(38)20-3-2-4-22(13-20)29(30,31)32)21-14-26(19-7-11-39-12-8-19)35-27(15-21)36-9-5-24(37)6-10-36;1-19-5-6-24(33-28(38)21-3-2-4-23(15-21)29(30,31)32)18-25(19)22-16-26(20-7-13-39-14-8-20)34-27(17-22)35(9-11-36)10-12-37;1-19-3-4-23(33-28(38)21-5-8-32-26(16-21)29(2,30)31)18-24(19)22-15-25(20-6-13-39-14-7-20)34-27(17-22)35(9-11-36)10-12-37;1-17-23(15-21(16-33-17)34-27(38)19-2-7-32-25(13-19)28(29,30)31)20-12-24(18-5-10-39-11-6-18)35-26(14-20)36-8-3-22(37)4-9-36;1-16-2-3-19(32-24(35)17-4-7-31-22(12-17)26(28,29)30)15-20(16)18-13-21(25(27)5-9-36-10-6-25)33-23(14-18)37-11-8-34/h2-4,13-17,19,24,37H,5-12H2,1H3,(H,34,38);2-6,15-18,20,36-37H,7-14H2,1H3,(H,33,38);3-5,8,15-18,20,36-37H,6-7,9-14H2,1-2H3,(H,33,38);2,7,12-16,18,22,37H,3-6,8-11H2,1H3,(H,34,38);2-4,7,12-15,34H,5-6,8-11H2,1H3,(H,32,35) |
| InChIKey | MXUMCPHPKOBQHY-UHFFFAOYSA-N |
| XLogP | 25.14 |
| TPSA | 484.35 Ų |
| H-Bond Donors | 12 |
| H-Bond Acceptors | 32 |
| Rotatable Bonds | 36 |
| Heavy Atoms | 193 |
| Complexity | — |
4 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 2685.85 |
| LogP ≤ 5 | 25.14 |
| H-Bond Donors ≤ 5 | 12 |
| H-Bond Acceptors ≤ 10 | 32 |